HIGHLIGHTS
- who: Guangzhi Liao et al. from the Department of Cardiology, West China Hospital, Sichuan University, Guoxue Street have published the research work: Antidyslipidemia Pharmacotherapy in Chronic Kidney Disease: A Systematic Review and Bayesian Network Meta-Analysis, in the Journal: Pharmaceutics 2023, 6 of 28/02/2022
- what: The authors excluded trials for the following reasons: trials that used quasirandom methods; and studies enrolling mostly patients who underwent kidney transplants or were on the transplant waiting list. Inthat addition, the work provided some other its uncertain safety , the study indicated that this prescription might be associated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.